Nab-paclitaxel: A new standard of care in neoadjuvant therapy of high-risk early breast cancer?

Masey Ross; Charles E. Geyer

doi:10.1200/JCO.19.00877

Nab-paclitaxel: A new standard of care in neoadjuvant therapy of high-risk early breast cancer?

Masey Ross, Charles E. Geyer

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	2196-2200
Number of pages	5
Journal	Journal of Clinical Oncology
Volume	37
Issue number	25
DOIs	https://doi.org/10.1200/JCO.19.00877
State	Published - Sep 1 2019

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.19.00877

Cite this

@article{646f0b33fdb344678b2d9b08d1b4de46,

title = "Nab-paclitaxel: A new standard of care in neoadjuvant therapy of high-risk early breast cancer?",

author = "Masey Ross and Geyer, \{Charles E.\}",

year = "2019",

month = sep,

day = "1",

doi = "10.1200/JCO.19.00877",

language = "English (US)",

volume = "37",

pages = "2196--2200",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "25",

}

TY - JOUR

T1 - Nab-paclitaxel

T2 - A new standard of care in neoadjuvant therapy of high-risk early breast cancer?

AU - Ross, Masey

AU - Geyer, Charles E.

PY - 2019/9/1

Y1 - 2019/9/1

UR - https://www.scopus.com/pages/publications/85071399893

UR - https://www.scopus.com/inward/citedby.url?scp=85071399893&partnerID=8YFLogxK

U2 - 10.1200/JCO.19.00877

DO - 10.1200/JCO.19.00877

M3 - Review article

C2 - 31306044

AN - SCOPUS:85071399893

SN - 0732-183X

VL - 37

SP - 2196

EP - 2200

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 25

ER -

Nab-paclitaxel: A new standard of care in neoadjuvant therapy of high-risk early breast cancer?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this